Impact of FDI on Economic development of India (Pharmaceutical Sector) and difficulties faced during Pandemic

The Indian pharmaceutical business has been seeing tremendous expansion in recent years, driven by increased domestic consumption and strong demand from export markets. The sector has made great progress in terms of infrastructure development, technical basis, and product variety. Because of Indian pharmaceutical companies' capacity to create cost-effective pharmaceuticals, demand from the export market has been constantly increasing. The goal of this study is to examine the before and aftereffects of FDI in pharmaceuticals on Indian economy. Whether Indian pharma need Foreign Direct Investments for its global developments and influence of foreign direct investment on India's pharmaceutical industry. Evidence collected from Invest India (National Investment Promotion and Facilitation Agency) and IBEF (India Brand equity foundation) are presented that justifies the impact of FDI on Indian pharma growth. Following that, the challenges encountered by the pharmaceutical industry during the Pandemic are highlighted. The difficulties involved in the manufacture and distribution of medicines and other requirements. This review focuses on the Indian pharmaceutical industry's response to the epidemic and at the economic impact of COVID-19 across segments and what it means for the Indian economy. This thesis is structured around the world pharma market and the competitive environment we see, India¿s Pharma market, its exports and Key players, Economic attractiveness of the pharma market in India. It also offers an overview of the synergy that may be produced because of India's low-cost labor maximizing returns and its fast-growing economy allowing the expansion of the pharma industry.